Swiftscale, Dr. Jewett's Company and CSB Start-up, is Helping to Address the Need for Rapid Biomanufacturing

Read more on Dr. Jewett’s company and CSB Start-up in the news articles below:

Northwestern News | Cell-free Biotechnology Could Help Accelerate COVID-19 Therapeutics
WIRED | Chafing Against Regulation, Silicon Valley Pivots to Pandemic
AXIOS | The Race to Make Vaccines Faster
Forbes | Chicago Is Uniting for the Greater Good
AIMBE | Cell-free Biotechnology Could Help Accelerate COVID-19 Therapeutics
Illinois Channel | Northwestern Researchers Take Unique Approach, Looking Outside of Cells for a COVID-19 Treatment

Skip Links